Neuronetics is a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Co.'s commercial product, NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is used to treat adult patients with major depressive disorder who have failed to achieve improvement from prior antidepressant medication in the current episode. The STIM stock yearly return is shown above.
The yearly return on the STIM stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2019 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the STIM annual return calculation with any dividends reinvested as applicable (on ex-dates).
|